Imagine bringing expert-level intelligence — and, likely, far beyond — to every moment of every day of a business’s life, ensuring that problems are anticipated as far in advance as possible and addressed in the very first moment action can be taken.
AGI will be able to actively manage large, complex networks, such as urban traffic flow, global supply chains, and energy grids, adapting in real time to the real world. In the chemical and biological sciences, AGI will create AI alchemists with the ability to control vast numbers of molecules and design and produce novel materials such as proteins for biotechnology and medical research and crystal structures that lead to entirely new alloys and materials.
AGI will also accelerate technology to create more powerful, intelligent robots. Whether that takes the form of Hollywood-style bipedal robots or something else entirely, it’s all but certain that AGI wouldn’t just change knowledge work, but labour as we know it.
Highly-efficient machines at warehouses, factories, farms and other facilities will take the baton from human operators and unleash productivity and throughput never before possible, all while reducing accidents, mistakes and defects. At some point AGI might be able to encompass all of the mammalian senses — sight, sound, smell, taste and touch — creating an entirely new robotic species.
In addition, connecting the human brain to AI systems that can read signals directly from the brain has enormous potential for a variety of tasks. Neural prosthetics will improve the functions of the brain, such as memory loss or the damage caused by a stroke, and AI-enabled limbs would bridge humans and robotics. VR and AR experiences could be more immersive and intuitive by directly tapping into the user’s neural response. And, eventually, the human brain and AGIs could form a more symbiotic relationship that becomes a new species.
Salesforce ProGen — an AI language model trained on the largest protein database available — shows how generative AI can lead to potential solutions for addressing challenges in human disease and the environment.